SB 2880 Aims to Criminalize Online Pill Providers, Abortion Funds in Texas

Texas lawmakers are pushing forward one of the most stringent anti-abortion measures in the nation, with a bill aimed at criminalizing online access to abortion pills, targeting support for abortions conducted out of state, and broadening the state's enforcement powers. Senate Bill 2880, introduced by Sen. Bryan Hughes (R-Mineola), was the center of a passionate Senate State Affairs Committee hearing on Thursday, garnering significant backing from anti-abortion proponents.

The legislation, characterized by legal experts as the most extensive effort to limit abortion access following Roe v. Wade, would classify the payment for or reimbursement of abortion costs as a felony, carrying a potential sentence of up to life in prison. This would effectively dismantle abortion funds that assist Texans in traveling out of state for legal procedures.

SB 2880 also focuses on online abortion pill providers, internet service platforms, and tech companies that host or facilitate content related to abortion. Hughes stated that the bill seeks to dismantle the framework that enables Texans to bypass the state's nearly complete abortion ban. “This concerns safeguarding lives and halting the illegal trade of harmful drugs,” he asserted.

The proposed legislation would grant the Texas attorney general greater authority to pursue alleged abortion-related offenses and broaden the capacity for private individuals to initiate wrongful death lawsuits against providers of abortion pills. Proponents argue that the legislation serves as an essential measure in combating what they describe as “unregulated, dangerous abortions.”

During the hearing, anti-abortion groups asserted that abortion pills such as mifepristone and misoprostol are being sent to pregnant Texans without sufficient medical oversight. Providers provided testimony regarding women who reportedly experienced complications due to inadequate follow-up care.

Medical experts highlight a substantial body of research indicating that mifepristone, which received FDA approval in 2000, is both safe and effective when used according to guidelines.

Opponents of SB 2880 contend that it would significantly restrict bodily autonomy, penalize reproductive health assistance, and raise issues of digital surveillance regarding personal health choices. Supporters such as John Seago, president of Texas Right to Life, praised the bill as a model for other states: “Texas will be leading the way.”

‍